FDA Form 483 – punishment or learning opportunity?

Generics and biosimilars Initiative

Building trust in cost-effective treatments

Inscribirse
eng / esp

FDA Form 483 – punishment or learning opportunity?

INICIO/Directrices | Posted 10/08/2010 1 Post your comment

The US FDA is authorised to perform inspections under the Federal Food, Drug, and Cosmetic Act. The FDA Form 483 is a form used by the FDA to document and communicate concerns discovered during these inspections and to list items that deviate from Good Manufacturing Practices.

The reaction of the clinical research community to the issuance of these Form 483s borders on paranoia — paranoia at the prospect of an FDA audit resulting in the issuance of the dreaded Form 483, an action that some liken to the kiss of death for the recipient.

The recipient of a Form 483 should respond to the FDA, addressing each item, indicating agreement and either providing a timeline for correction or requesting clarification. Since September 2009, this response must be submitted within 15 working days, regardless of the number of observations. While a response is not compulsory, a good response can usually help a company avoid receiving a warning letter from the FDA, which may mean withholding of product approval, or plant shut-down.

The original intent of the Form 483 is to be an instrument of prompt notification to allow the inspected entity an opportunity for correction and improvement, not an instrument of punishment.

The US FDA has jurisdiction only within the US. However, the supply chain for pharmaceuticals often extends far beyond borders. The agency therefore performs foreign inspections and observations, which are also captured on a Form 483. Although they have no legal authority outside of the US they can restrict imports into the US.

References:

FDA. Regulatory information. FD&C Act SEC. 704. (21 USC §374) Factory Inspection

Federal Register: August 11, 2009 (Volume 74, Number 153) Notices [Page 40211-40212]

Comments (1)

Post your comment

Posted 25/03/2011 by Tony @ FDAzilla.com

avoiding 483s in the first place

Based on our data, 2010 represents an all-time high for the number of FDA 483s issued by the FDA. And there's no reason for 2011 not to be another record-breaking year. As such, we've put together a list of top 10 resources for avoiding (and responding to) 483s.

You're absolutely right, though. You're not required to respond to 483s, but you'd be foolish not to. You should respond as comprehensively, swiftly, and logically as possible. And make sure you respond to every single observation individually. Good luck.